Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio. 1979

G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen

This paper describes measurements of the aerobic cytotoxicity of 42 nitroaromatic and nitroheterocyclic compounds towards Chinese Hamster cells in vitro. The results of acute and chronic exposure were quantified, and the concentration C required to achieve a standard response estimated. Fitting the data to an equation of the form - log C = b0 + b1E, where E is the one-electron reduction potential, explained 47 and 71 per cent of the variance in the acute and chronic aerobic cytotoxicity respectively. The addition of further terms to the equation, quantifying partition properties, was not statistically significant. The coefficient b1 was similar for both acute and chronic exposure; the dependence of both cytotoxicity and radiosensitization efficiency on reduction potential was also similar. A therapeutic ratio derived from these in vitro measurements showed no dependence on redox or partition properties. The insensitivity of cytotoxicity and radiosensitization properties to variations in molecular structure, other than those which influence redox behaviour, offers exceptional flexibility in developing compounds of improved therapeutic ratio.

UI MeSH Term Description Entries
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D008920 Misonidazole A nitroimidazole that sensitizes normally radio-resistant hypoxic cells to radiation. It may also be directly cytotoxic to hypoxic cells and has been proposed as an antineoplastic. Ro 07-0582,Ro 7-0582,alpha-(Methoxymethyl)-2-nitro-1H-imidazole-1-ethanol,Ro 07 0582,Ro 070582,Ro 7 0582,Ro 70582
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009593 Nitroimidazoles IMIDAZOLES having a nitro moiety. Nitroimidazole
D010100 Oxygen An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. Dioxygen,Oxygen-16,Oxygen 16
D011838 Radiation-Sensitizing Agents Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. Radiation Sensitizer,Radiosensitizing Agent,Radiosensitizing Agents,Agents, Radiation-Sensitizing,Radiation Sensitizers,Radiation Sensitizing Agents,Radiation-Sensitizing Drugs,Radiation-Sensitizing Effect,Radiation-Sensitizing Effects,Radiosensitizing Drugs,Radiosensitizing Effect,Radiosensitizing Effects,Agent, Radiosensitizing,Agents, Radiation Sensitizing,Agents, Radiosensitizing,Drugs, Radiation-Sensitizing,Drugs, Radiosensitizing,Effect, Radiation-Sensitizing,Effect, Radiosensitizing,Effects, Radiation-Sensitizing,Effects, Radiosensitizing,Radiation Sensitizing Drugs,Radiation Sensitizing Effect,Radiation Sensitizing Effects,Sensitizer, Radiation,Sensitizers, Radiation,Sensitizing Agents, Radiation
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003412 Cricetulus A genus of the family Muridae consisting of eleven species. C. migratorius, the grey or Armenian hamster, and C. griseus, the Chinese hamster, are the two species used in biomedical research. Hamsters, Armenian,Hamsters, Chinese,Hamsters, Grey,Armenian Hamster,Armenian Hamsters,Chinese Hamster,Chinese Hamsters,Grey Hamster,Grey Hamsters,Hamster, Armenian,Hamster, Chinese,Hamster, Grey

Related Publications

G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen
June 1979, The British journal of radiology,
G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen
November 1979, Radiology,
G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen
January 1978, Strahlentherapie. Sonderbande,
G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen
February 1985, International journal of radiation oncology, biology, physics,
G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen
June 1978, The British journal of cancer. Supplement,
G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen
June 1976, The New England journal of medicine,
G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen
December 1981, International journal of radiation biology and related studies in physics, chemistry, and medicine,
G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen
June 1978, The British journal of cancer. Supplement,
G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen
June 1981, International journal of radiation oncology, biology, physics,
G E Adams, and E D Clarke, and P Gray, and R S Jacobs, and I J Stratford, and P Wardman, and M E Watts, and J Parrick, and R G Wallace, and C E Smithen
January 1980, Cancer clinical trials,
Copied contents to your clipboard!